Literature DB >> 3290257

Mild type II diabetes markedly increases glucose cycling in the postabsorptive state and during glucose infusion irrespective of obesity.

S Efendic1, S Karlander, M Vranic.   

Abstract

Glucose cycling (GC; G in equilibrium G6P) equals 14% of glucose production in postabsorptive man. Our aim was to determine glucose cycling in six lean and six overweight mild type II diabetics (fasting glycemia: 139 +/- 10 and 152 +/- 7 mg/dl), in postabsorptive state (PA) and during glucose infusion (2 mg/kg per min). 14 control subjects were weight and age matched. GC is a function of the enzyme that catalyzes the reaction opposite the net flux and is the difference between hepatic total glucose output (HTGO) (2-[3H]glucose) and hepatic glucose production (HGP) (6-[3H]-glucose). Postabsorptively, GC is a function of glucokinase. With glucose infusion the flux is reversed (net glucose uptake), and GC is a function of glucose 6-phosphatase. In PA, GC was increased by 100% in lean (from 0.25 +/- 0.07 to 0.43 +/- .08 mg/kg per min) and obese (from 0.22 +/- 0.05 to 0.50 +/- 0.07) diabetics. HGP and HTGO increased in lean and obese diabetics by 41 and 33%. Glucose infusion suppressed apparent phosphatase activity and gluconeogenesis much less in diabetics than controls, resulting in marked enhancement (400%) in HTGO and HGP, GC remained increased by 100%. Although the absolute responses of C-peptide and insulin were comparable to those of control subjects, they were inappropriate for hyperglycemia. Peripheral insulin resistance relates to decreased metabolic glucose clearance (MCR) and inadequate increase of uptake during glucose infusion. We conclude that increases in HGP and HTGO and a decrease of MCR are characteristic features of mild type II diabetes and are more pronounced during glucose infusion. There is also an increase in hepatic GC, a stopgap that controls changes from glucose production to uptake. Postabsorptively, this limits the increase of HGP and glycemia. In contrast, during glucose infusion, increased GC decreases hepatic glucose uptake and thus contributes to hyperglycemia. Obesity per se did not affect GC. An increase in glucose cycling and turnover indicate hepatic insulin resistance that is observed in addition to peripheral resistance. It is hypothesized that in pathogenesis of type II diabetes, augmented activity of glucose-6-phosphatase and kinase may be of importance.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3290257      PMCID: PMC442648          DOI: 10.1172/JCI113543

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  41 in total

Review 1.  Substrate cycles in metabolic regulation and in heat generation.

Authors:  E A Newsholme; B Crabtree
Journal:  Biochem Soc Symp       Date:  1976

Review 2.  Assessment of insulin sensitivity in vivo.

Authors:  R N Bergman; D T Finegood; M Ader
Journal:  Endocr Rev       Date:  1985       Impact factor: 19.871

3.  Glucose turnover values in the dog obtained with various species of labeled glucose.

Authors:  N Altszuler; A Barkai; C Bjerknes; B Gottlieb; R Steele
Journal:  Am J Physiol       Date:  1975-12

4.  Estimation of glucose turnover and recycling in rabbits using various [3H, 14C]glucose labels.

Authors:  A Dunn; J Katz; S Golden; M Chenoweth
Journal:  Am J Physiol       Date:  1976-04

5.  Effects of insulin on peripheral and splanchnic glucose metabolism in noninsulin-dependent (type II) diabetes mellitus.

Authors:  R A DeFronzo; R Gunnarsson; O Björkman; M Olsson; J Wahren
Journal:  J Clin Invest       Date:  1985-07       Impact factor: 14.808

6.  Assessment of insulin action in insulin-dependent diabetes mellitus using [6(14)C]glucose, [3(3)H]glucose, and [2(3)H]glucose. Differences in the apparent pattern of insulin resistance depending on the isotope used.

Authors:  P M Bell; R G Firth; R A Rizza
Journal:  J Clin Invest       Date:  1986-12       Impact factor: 14.808

7.  Experimental validation of measurements of glucose turnover in nonsteady state.

Authors:  J Radziuk; K H Norwich; M Vranic
Journal:  Am J Physiol       Date:  1978-01

8.  Increased glucose turnover and glucose cycling in acromegalic patients with normal glucose tolerance.

Authors:  S Karlander; M Vranić; S Efendić
Journal:  Diabetologia       Date:  1986-11       Impact factor: 10.122

9.  Increased activity of the glucose cycle in the liver: early characteristic of type 2 diabetes.

Authors:  S Efendić; A Wajngot; M Vranić
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

10.  Evidence for suppression of hepatic glucose-6-phosphatase with carbohydrate feeding.

Authors:  C B Newgard; D W Foster; J D McGarry
Journal:  Diabetes       Date:  1984-02       Impact factor: 9.461

View more
  14 in total

1.  The deacetylase Sirt6 activates the acetyltransferase GCN5 and suppresses hepatic gluconeogenesis.

Authors:  John E Dominy; Yoonjin Lee; Mark P Jedrychowski; Helen Chim; Michael J Jurczak; Joao Paulo Camporez; Hai-Bin Ruan; Jessica Feldman; Kerry Pierce; Raul Mostoslavsky; John M Denu; Clary B Clish; Xiaoyong Yang; Gerald I Shulman; Steven P Gygi; Pere Puigserver
Journal:  Mol Cell       Date:  2012-11-08       Impact factor: 17.970

2.  Nocturnal Glucose Metabolism in Type 1 Diabetes: A Study Comparing Single Versus Dual Tracer Approaches.

Authors:  Ashwini Mallad; Ling Hinshaw; Chiara Dalla Man; Claudio Cobelli; Rita Basu; Ravi Lingineni; Rickey E Carter; Yogish C Kudva; Ananda Basu
Journal:  Diabetes Technol Ther       Date:  2015-06-29       Impact factor: 6.118

3.  Regulation of endogenous glucose production by glucose per se is impaired in type 2 diabetes mellitus.

Authors:  M Mevorach; A Giacca; Y Aharon; M Hawkins; H Shamoon; L Rossetti
Journal:  J Clin Invest       Date:  1998-08-15       Impact factor: 14.808

Review 4.  Metabolic origin of insulin resistance in obesity with and without type 2 (non-insulin-dependent) diabetes mellitus.

Authors:  J P Felber; E Haesler; E Jéquier
Journal:  Diabetologia       Date:  1993-12       Impact factor: 10.122

5.  Mechanism by which hyperglycemia inhibits hepatic glucose production in conscious rats. Implications for the pathophysiology of fasting hyperglycemia in diabetes.

Authors:  L Rossetti; A Giaccari; N Barzilai; K Howard; G Sebel; M Hu
Journal:  J Clin Invest       Date:  1993-09       Impact factor: 14.808

Review 6.  Glucose-6-phosphatase catalytic subunit gene family.

Authors:  John C Hutton; Richard M O'Brien
Journal:  J Biol Chem       Date:  2009-08-20       Impact factor: 5.157

7.  Hepatocyte nuclear factor-1 acts as an accessory factor to enhance the inhibitory action of insulin on mouse glucose-6-phosphatase gene transcription.

Authors:  R S Streeper; E M Eaton; D H Ebert; S C Chapman; C A Svitek; R M O'Brien
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-04       Impact factor: 11.205

8.  Contribution of glucose/glucose 6-phosphate cycle activity to insulin resistance in type 2 (non-insulin-dependent) diabetes mellitus.

Authors:  D P Rooney; R D Neely; O Beatty; N P Bell; B Sheridan; A B Atkinson; E R Trimble; P M Bell
Journal:  Diabetologia       Date:  1993-02       Impact factor: 10.122

9.  Importance of peripheral insulin levels for insulin-induced suppression of glucose production in depancreatized dogs.

Authors:  A Giacca; S J Fisher; Z Q Shi; R Gupta; H L Lickley; M Vranic
Journal:  J Clin Invest       Date:  1992-11       Impact factor: 14.808

10.  Hepatic glucose sensing is impaired, but can be normalized, in people with impaired fasting glucose.

Authors:  Leigh Perreault; Kristine Færch; Anna A Kerege; Samantha D Bacon; Bryan C Bergman
Journal:  J Clin Endocrinol Metab       Date:  2014-04-14       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.